Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein

Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are major end-products of oxidation of polyunsaturated fatty acids, and are frequently measured as indicators of lipid peroxidation and oxidative stress in vivo. MDA forms Schiff-base adducts with lysine residues and cross-links proteins in vitro; HNE...

Full description

Saved in:
Bibliographic Details
Published inBiochemical journal Vol. 322; no. 1; pp. 317 - 325
Main Authors REQUENA, Jesús R., FU, Min Xin, AHMED, Mahtab U., JENKINS, Alicia J., LYONS, Timothy J., BAYNES, John W., THORPE, Suzanne R.
Format Journal Article
LanguageEnglish
Published England 15.02.1997
Subjects
Online AccessGet full text
ISSN0264-6021
1470-8728
DOI10.1042/bj3220317

Cover

Loading…
Abstract Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are major end-products of oxidation of polyunsaturated fatty acids, and are frequently measured as indicators of lipid peroxidation and oxidative stress in vivo. MDA forms Schiff-base adducts with lysine residues and cross-links proteins in vitro; HNE also reacts with lysines, primarily via a Michael addition reaction. We have developed methods using NaBH4 reduction to stabilize these adducts to conditions used for acid hydrolysis of protein, and have prepared reduced forms of lysine-MDA [3-(Nε-lysino)propan-1-ol (LM)], the lysine-MDA-lysine iminopropene cross-link [1,3-di(Nε-lysino)propane (LML)] and lysine-HNE [3-(Nε-lysino)-4-hydroxynonan-1-ol (LHNE)]. Gas chromatography/MS assays have been developed for quantification of the reduced compounds in protein. RNase incubated with MDA or HNE was used as a model for quantification of the adducts by gas chromatography/MS. There was excellent agreement between measurement of MDA bound to RNase as LM and LML, and as thiobarbituric acid-MDA adducts measured by HPLC; these adducts accounted for 70Ő80% of total lysine loss during the reaction with MDA. LM and LML (0.002Ő0.12mmol/mol of lysine) were also found in freshly isolated low-density lipoprotein (LDL) from healthy subjects. LHNE was measured in RNase treated with HNE, but was not detectable in native LDL. LM, LML and LHNE increased in concert with the formation of conjugated dienes during the copper-catalysed oxidation of LDL, but accounted for modification of < 1% of lysine residues in oxidized LDL. These results are the first report of direct chemical measurement of MDA and HNE adducts to lysine residues in LDL. LM, LML and LHNE should be useful as biomarkers of lipid peroxidative modification of protein and of oxidative stress in vitro and in vivo.
AbstractList Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are major end-products of oxidation of polyunsaturated fatty acids, and are frequently measured as indicators of lipid peroxidation and oxidative stress in vivo. MDA forms Schiff-base adducts with lysine residues and cross-links proteins in vitro; HNE also reacts with lysines, primarily via a Michael addition reaction. We have developed methods using NaBH4 reduction to stabilize these adducts to conditions used for acid hydrolysis of protein, and have prepared reduced forms of lysine-MDA [3-(N epsilon-lysino)propan-1-ol (LM)], the lysine-MDA-lysine iminopropene cross-link [1,3-di(N epsilon-lysino)propane (LML)] and lysine-HNE [3-(N epsilon-lysino)-4-hydroxynonan-l-ol (LHNE)]. Gas chromatography/MS assays have been developed for quantification of the reduced compounds in protein. RNase incubated with MDA or HNE was used as a model for quantification of the adducts by gas chromatography/MS. There was excellent agreement between measurement of MDA bound to RNase as LM and LML, and as thiobarbituric acid-MDA adducts measured by HPLC; these adducts accounted for 70-80% of total lysine loss during the reaction with MDA. LM and LML (0.002-0.12 mmol/ mol of lysine) were also found in freshly isolated low-density lipoprotein (LDL) from healthy subjects. LHNE was measured in RNase treated with HNE, but was not detectable in native LDL. LM, LML and LHNE increased in concert with the formation of conjugated dienes during the copper-catalysed oxidation of LDL, but accounted for modification of < 1% of lysine residues in oxidized LDL. These results are the first report of direct chemical measurement of MDA and HNE adducts to lysine residues in LDL. LM, LML and LHNE should be useful as biomarkers of lipid peroxidative modification of protein and of oxidative stress in vitro and in vivo.
Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are major end-products of oxidation of polyunsaturated fatty acids, and are frequently measured as indicators of lipid peroxidation and oxidative stress in vivo. MDA forms Schiff-base adducts with lysine residues and cross-links proteins in vitro; HNE also reacts with lysines, primarily via a Michael addition reaction. We have developed methods using NaBH4 reduction to stabilize these adducts to conditions used for acid hydrolysis of protein, and have prepared reduced forms of lysine-MDA [3-(N epsilon-lysino)propan-1-ol (LM)], the lysine-MDA-lysine iminopropene cross-link [1,3-di(N epsilon-lysino)propane (LML)] and lysine-HNE [3-(N epsilon-lysino)-4-hydroxynonan-l-ol (LHNE)]. Gas chromatography/MS assays have been developed for quantification of the reduced compounds in protein. RNase incubated with MDA or HNE was used as a model for quantification of the adducts by gas chromatography/MS. There was excellent agreement between measurement of MDA bound to RNase as LM and LML, and as thiobarbituric acid-MDA adducts measured by HPLC; these adducts accounted for 70-80% of total lysine loss during the reaction with MDA. LM and LML (0.002-0.12 mmol/ mol of lysine) were also found in freshly isolated low-density lipoprotein (LDL) from healthy subjects. LHNE was measured in RNase treated with HNE, but was not detectable in native LDL. LM, LML and LHNE increased in concert with the formation of conjugated dienes during the copper-catalysed oxidation of LDL, but accounted for modification of < 1% of lysine residues in oxidized LDL. These results are the first report of direct chemical measurement of MDA and HNE adducts to lysine residues in LDL. LM, LML and LHNE should be useful as biomarkers of lipid peroxidative modification of protein and of oxidative stress in vitro and in vivo.Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are major end-products of oxidation of polyunsaturated fatty acids, and are frequently measured as indicators of lipid peroxidation and oxidative stress in vivo. MDA forms Schiff-base adducts with lysine residues and cross-links proteins in vitro; HNE also reacts with lysines, primarily via a Michael addition reaction. We have developed methods using NaBH4 reduction to stabilize these adducts to conditions used for acid hydrolysis of protein, and have prepared reduced forms of lysine-MDA [3-(N epsilon-lysino)propan-1-ol (LM)], the lysine-MDA-lysine iminopropene cross-link [1,3-di(N epsilon-lysino)propane (LML)] and lysine-HNE [3-(N epsilon-lysino)-4-hydroxynonan-l-ol (LHNE)]. Gas chromatography/MS assays have been developed for quantification of the reduced compounds in protein. RNase incubated with MDA or HNE was used as a model for quantification of the adducts by gas chromatography/MS. There was excellent agreement between measurement of MDA bound to RNase as LM and LML, and as thiobarbituric acid-MDA adducts measured by HPLC; these adducts accounted for 70-80% of total lysine loss during the reaction with MDA. LM and LML (0.002-0.12 mmol/ mol of lysine) were also found in freshly isolated low-density lipoprotein (LDL) from healthy subjects. LHNE was measured in RNase treated with HNE, but was not detectable in native LDL. LM, LML and LHNE increased in concert with the formation of conjugated dienes during the copper-catalysed oxidation of LDL, but accounted for modification of < 1% of lysine residues in oxidized LDL. These results are the first report of direct chemical measurement of MDA and HNE adducts to lysine residues in LDL. LM, LML and LHNE should be useful as biomarkers of lipid peroxidative modification of protein and of oxidative stress in vitro and in vivo.
Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are major end-products of oxidation of polyunsaturated fatty acids, and are frequently measured as indicators of lipid peroxidation and oxidative stress in vivo. MDA forms Schiff-base adducts with lysine residues and cross-links proteins in vitro; HNE also reacts with lysines, primarily via a Michael addition reaction. We have developed methods using NaBH4 reduction to stabilize these adducts to conditions used for acid hydrolysis of protein, and have prepared reduced forms of lysine-MDA [3-(Nε-lysino)propan-1-ol (LM)], the lysine-MDA-lysine iminopropene cross-link [1,3-di(Nε-lysino)propane (LML)] and lysine-HNE [3-(Nε-lysino)-4-hydroxynonan-1-ol (LHNE)]. Gas chromatography/MS assays have been developed for quantification of the reduced compounds in protein. RNase incubated with MDA or HNE was used as a model for quantification of the adducts by gas chromatography/MS. There was excellent agreement between measurement of MDA bound to RNase as LM and LML, and as thiobarbituric acid-MDA adducts measured by HPLC; these adducts accounted for 70Ő80% of total lysine loss during the reaction with MDA. LM and LML (0.002Ő0.12mmol/mol of lysine) were also found in freshly isolated low-density lipoprotein (LDL) from healthy subjects. LHNE was measured in RNase treated with HNE, but was not detectable in native LDL. LM, LML and LHNE increased in concert with the formation of conjugated dienes during the copper-catalysed oxidation of LDL, but accounted for modification of < 1% of lysine residues in oxidized LDL. These results are the first report of direct chemical measurement of MDA and HNE adducts to lysine residues in LDL. LM, LML and LHNE should be useful as biomarkers of lipid peroxidative modification of protein and of oxidative stress in vitro and in vivo.
Author FU, Min Xin
JENKINS, Alicia J.
THORPE, Suzanne R.
AHMED, Mahtab U.
BAYNES, John W.
LYONS, Timothy J.
REQUENA, Jesús R.
AuthorAffiliation Department of Chemistry and Biochemistry, University of South Carolina, Columbia 29208, USA
AuthorAffiliation_xml – name: Department of Chemistry and Biochemistry, University of South Carolina, Columbia 29208, USA
Author_xml – sequence: 1
  givenname: Jesús R.
  surname: REQUENA
  fullname: REQUENA, Jesús R.
  organization: Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, U.S.A., Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, U.S.A
– sequence: 2
  givenname: Min Xin
  surname: FU
  fullname: FU, Min Xin
  organization: Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, U.S.A
– sequence: 3
  givenname: Mahtab U.
  surname: AHMED
  fullname: AHMED, Mahtab U.
  organization: Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, U.S.A
– sequence: 4
  givenname: Alicia J.
  surname: JENKINS
  fullname: JENKINS, Alicia J.
  organization: Department of Medicine, Medical University of South Carolina, Charleston, SC 29245, U.S.A
– sequence: 5
  givenname: Timothy J.
  surname: LYONS
  fullname: LYONS, Timothy J.
  organization: Department of Medicine, Medical University of South Carolina, Charleston, SC 29245, U.S.A
– sequence: 6
  givenname: John W.
  surname: BAYNES
  fullname: BAYNES, John W.
  organization: Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, U.S.A., Department of School of Medicine, University of South Carolina, Columbia, SC 29208, U.S.A
– sequence: 7
  givenname: Suzanne R.
  surname: THORPE
  fullname: THORPE, Suzanne R.
  organization: Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, U.S.A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9078279$$D View this record in MEDLINE/PubMed
BookMark eNplkUtr3DAUhUVJSCdpF_0BBa0KXTjRayx7Uyihj0CgBNK10OO6oyBLU0tO4v6A_u4qmWnoYyXBuec73HuO0UFMERB6RckpJYKdmRvOGOFUPkMrKiRpOsm6A7QirBVNSxh9jo5zviGECiLIETrqieyY7Ffo59WsY_GDt7r4FHEa8KhDis7r4GCzOMA6Oiya-p3S_fIQHHXA2rnZloxLwmHJPgKeIHs3Q8Y-4lhhtztnuvfO_wCHN_OoIw7prnEQsy8LDn6btlMq4OMLdDjokOHl_j1BXz9-uD7_3Fx--XRx_v6ysYK3paGcaurWlDFRVwFnpe0HI6BtueVAKePamLXsjCDd4FoijBCgNeulkYZwzk_Qux13O5ux-iGWSQe1nfyop0Ul7dXfSvQb9S3dKspoR3tRAW_2gCl9r9sWNfpsIQQdIc1Zya4na877Ovj6z6SniP3lq3620-2Ucp5gUNaXxw5qrg-KEvVQrXqqtjre_uP4zfx_9hdSyafL
CitedBy_id crossref_primary_10_1016_j_ijantimicag_2016_11_011
crossref_primary_10_1155_2018_5123147
crossref_primary_10_1007_s10620_012_2321_2
crossref_primary_10_1096_fj_06_7536com
crossref_primary_10_1021_tx010055u
crossref_primary_10_1016_S0014_5793_97_01554_8
crossref_primary_10_3390_antiox9111132
crossref_primary_10_18097_pbmc20206606437
crossref_primary_10_1016_j_cbi_2011_01_007
crossref_primary_10_1016_j_bbrc_2010_02_043
crossref_primary_10_1002_adfm_202112000
crossref_primary_10_3109_09546634_2010_521812
crossref_primary_10_1006_clim_2000_4857
crossref_primary_10_1016_j_ejphar_2008_06_110
crossref_primary_10_4308_hjb_14_3_87
crossref_primary_10_1016_S0211_139X_06_72922_5
crossref_primary_10_1021_tx700059b
crossref_primary_10_3390_ijms18050984
crossref_primary_10_1002_rcm_1283
crossref_primary_10_1128_CDLI_12_1_68_75_2005
crossref_primary_10_1016_j_cccn_2003_09_005
crossref_primary_10_1016_j_mad_2004_06_002
crossref_primary_10_1021_bi0349975
crossref_primary_10_1021_es9026369
crossref_primary_10_1074_jbc_M109935200
crossref_primary_10_1007_s12013_014_0365_y
crossref_primary_10_1016_j_foodchem_2017_11_072
crossref_primary_10_1002_jms_381
crossref_primary_10_1016_j_apenergy_2016_01_087
crossref_primary_10_1080_10715760500250182
crossref_primary_10_1007_s11154_008_9093_1
crossref_primary_10_1021_acs_jafc_4c00335
crossref_primary_10_1093_gerona_55_6_B286
crossref_primary_10_1515_BC_2002_055
crossref_primary_10_3390_ijms23010211
crossref_primary_10_1089_ars_1999_1_3_255
crossref_primary_10_1089_ars_2017_7362
crossref_primary_10_1007_s10522_004_7380_0
crossref_primary_10_1046_j_1432_1033_2003_03598_x
crossref_primary_10_1179_135100005X57382
crossref_primary_10_1016_j_cbi_2010_12_028
crossref_primary_10_1016_j_foodchem_2006_09_004
crossref_primary_10_1016_S0006_291X_03_01038_6
crossref_primary_10_3390_ijms242015489
crossref_primary_10_1021_ja038756w
crossref_primary_10_1586_eem_10_68
crossref_primary_10_1007_s11357_012_9391_0
crossref_primary_10_1002_cmdc_200600075
crossref_primary_10_1007_s10522_006_9026_x
crossref_primary_10_1021_acs_jafc_2c04052
crossref_primary_10_1016_S1074_5521_01_00026_6
crossref_primary_10_1021_tx049838g
crossref_primary_10_1016_j_bbalip_2011_11_011
crossref_primary_10_1016_j_abb_2004_03_012
crossref_primary_10_1016_S0891_5849_97_00454_1
crossref_primary_10_1074_jbc_274_28_19661
crossref_primary_10_1194_jlr_M200370_JLR200
crossref_primary_10_1134_S1990750821020104
crossref_primary_10_3109_10715762_2015_1036052
crossref_primary_10_1016_j_exger_2004_01_006
crossref_primary_10_1186_1556_276X_8_190
crossref_primary_10_3390_ijms17111802
crossref_primary_10_1134_S0006297923120143
crossref_primary_10_1080_10715760600693422
crossref_primary_10_1002_mas_20006
crossref_primary_10_1134_S0006297907100069
crossref_primary_10_1016_S0891_5849_00_00226_4
crossref_primary_10_1194_jlr_M400095_JLR200
crossref_primary_10_1016_S0891_5849_00_00395_6
crossref_primary_10_1002_cbic_200500109
crossref_primary_10_1134_S0022093021040050
crossref_primary_10_1016_j_biomaterials_2010_04_014
crossref_primary_10_1111_1751_7915_13723
crossref_primary_10_1021_jf903562c
crossref_primary_10_1016_j_amjcard_2003_12_028
crossref_primary_10_1096_fj_05_5568com
crossref_primary_10_1562_0031_8655_2004_79_21_GOFAOM_2_0_CO_2
crossref_primary_10_3153_JFHS16018
crossref_primary_10_1074_jbc_M608589200
crossref_primary_10_31857_S0320972523110209
crossref_primary_10_1089_ars_2023_0314
crossref_primary_10_1006_abio_1999_4243
crossref_primary_10_1016_j_mam_2012_09_001
crossref_primary_10_1196_annals_1333_043
crossref_primary_10_1002_jsfa_3606
crossref_primary_10_1006_abbi_2001_2583
crossref_primary_10_1016_S1383_5742_99_00008_3
crossref_primary_10_1007_s00405_013_2821_5
crossref_primary_10_1016_j_atherosclerosis_2007_10_035
crossref_primary_10_1016_S0047_6374_98_00121_3
crossref_primary_10_1002_ppap_201100031
crossref_primary_10_1046_j_1523_1755_2003_00027_x
crossref_primary_10_1080_07391102_2023_2208234
crossref_primary_10_3892_etm_2017_4766
crossref_primary_10_1016_j_abb_2008_11_007
crossref_primary_10_1007_s11010_012_1247_5
crossref_primary_10_1016_j_abb_2019_05_008
crossref_primary_10_1046_j_1471_4159_1999_0722601_x
crossref_primary_10_1134_S0006297909040154
crossref_primary_10_1016_j_mad_2005_04_005
crossref_primary_10_1002_ejlt_200501196
crossref_primary_10_4236_ojmc_2019_93003
crossref_primary_10_3390_nu12040974
crossref_primary_10_1196_annals_1333_061
crossref_primary_10_3390_foods11070903
crossref_primary_10_1002_mas_10076
crossref_primary_10_1016_j_jmb_2008_01_057
crossref_primary_10_1016_S0009_9120_99_00075_2
crossref_primary_10_1111_j_1474_9726_2010_00573_x
crossref_primary_10_1016_j_atherosclerosis_2013_11_068
crossref_primary_10_1016_S0968_0896_02_00311_5
crossref_primary_10_1111_ijfs_13016
crossref_primary_10_1155_2017_1625130
crossref_primary_10_1021_jf020201h
crossref_primary_10_1021_acs_chemrev_7b00698
crossref_primary_10_1016_j_aca_2003_12_040
crossref_primary_10_1016_j_freeradbiomed_2009_08_002
crossref_primary_10_1016_j_freeradbiomed_2013_06_032
crossref_primary_10_1021_cr300073p
crossref_primary_10_1007_s00726_006_0426_7
crossref_primary_10_1074_jbc_M304292200
crossref_primary_10_1021_tx1002854
crossref_primary_10_1016_S0891_5849_00_00469_X
crossref_primary_10_1196_annals_1333_050
crossref_primary_10_1194_jlr_M400442_JLR200
crossref_primary_10_1016_S0891_5849_00_00228_8
crossref_primary_10_1128_AEM_65_9_4094_4098_1999
crossref_primary_10_1253_circj_CJ_16_0451
crossref_primary_10_1016_j_brainres_2016_04_027
crossref_primary_10_1021_bi501111j
crossref_primary_10_1016_S0047_6374_01_00214_7
crossref_primary_10_1111_j_1749_6632_1998_tb09909_x
crossref_primary_10_1111_j_1751_1097_2004_tb09852_x
crossref_primary_10_1128_CDLI_10_4_499_505_2003
crossref_primary_10_1097_NEN_0b013e31820f8765
crossref_primary_10_1021_jf3026277
crossref_primary_10_1134_S0006297923110196
crossref_primary_10_1016_S0163_7827_98_00009_5
crossref_primary_10_1080_03602530600959508
crossref_primary_10_1021_acs_jafc_9b07978
crossref_primary_10_1074_jbc_M110_118182
crossref_primary_10_2337_db07_1204
crossref_primary_10_1016_j_metabol_2004_01_002
crossref_primary_10_1002_biof_5520240134
crossref_primary_10_1007_s11010_014_2144_x
crossref_primary_10_1196_annals_1333_086
crossref_primary_10_1074_jbc_M502255200
crossref_primary_10_1007_s11010_014_2131_2
crossref_primary_10_1096_fasebj_13_10_1157
crossref_primary_10_1080_10715760600902302
crossref_primary_10_1002_jat_976
crossref_primary_10_31857_S0320972523120138
crossref_primary_10_1016_S0006_2952_98_00266_4
crossref_primary_10_1016_j_ijfoodmicro_2021_109116
crossref_primary_10_1006_abbi_1998_0976
crossref_primary_10_1016_S0006_291X_03_01412_8
crossref_primary_10_1074_jbc_M702146200
crossref_primary_10_1016_j_jnutbio_2011_08_006
crossref_primary_10_1089_ars_2012_4877
crossref_primary_10_3390_antiox10081184
crossref_primary_10_1016_S0271_5317_99_00025_1
crossref_primary_10_1021_acs_jafc_0c03947
crossref_primary_10_1016_j_freeradbiomed_2012_09_038
crossref_primary_10_1074_jbc_M310608200
crossref_primary_10_1002_cbdv_200590074
crossref_primary_10_1021_tx050078z
crossref_primary_10_1016_S0891_5849_98_00149_X
crossref_primary_10_1021_ac7016184
crossref_primary_10_1016_j_foodchem_2024_141397
crossref_primary_10_1016_S0021_9673_98_01078_4
crossref_primary_10_1016_S0047_6374_02_00076_3
crossref_primary_10_1371_journal_pone_0058764
crossref_primary_10_1002_mas_20074
crossref_primary_10_1081_DMR_100102336
crossref_primary_10_12737_article_590823a4b59f98_13160142
crossref_primary_10_1016_j_bbalip_2008_03_002
crossref_primary_10_2337_diabetes_51_9_2826
crossref_primary_10_1073_pnas_95_9_4882
crossref_primary_10_1189_jlb_1211617
crossref_primary_10_3109_10715769809065821
crossref_primary_10_1007_s10557_011_6326_4
crossref_primary_10_1161_CIRCRESAHA_109_200568
crossref_primary_10_3390_ijms241310471
crossref_primary_10_1080_08923970902785253
crossref_primary_10_1508_cytologia_80_467
crossref_primary_10_3390_foods11152176
crossref_primary_10_1016_j_yexmp_2012_06_008
crossref_primary_10_1006_abbi_1997_0266
crossref_primary_10_1021_ol0348147
crossref_primary_10_1021_tx000007u
crossref_primary_10_1373_clinchem_2010_145201
crossref_primary_10_1016_S0891_5849_01_00811_5
crossref_primary_10_1016_S0014_5793_00_01539_8
crossref_primary_10_1089_rej_2014_1561
crossref_primary_10_1021_jf072385b
crossref_primary_10_1177_026119299802600411
crossref_primary_10_1016_j_matchemphys_2015_07_029
crossref_primary_10_1016_j_bbalip_2011_08_018
crossref_primary_10_1177_1744806920903848
crossref_primary_10_3390_foods13244153
crossref_primary_10_1016_S0378_4347_00_00030_X
crossref_primary_10_1016_j_aquaculture_2022_738861
crossref_primary_10_1016_S0925_4439_99_00087_3
crossref_primary_10_1007_s11357_005_4562_x
crossref_primary_10_1016_j_exger_2004_08_001
crossref_primary_10_1016_S0022_2275_20_31568_6
crossref_primary_10_1074_jbc_273_26_16058
crossref_primary_10_1002_advs_202302887
crossref_primary_10_1016_S1044_0305_02_00911_X
crossref_primary_10_1016_S0009_3084_03_00048_3
crossref_primary_10_1016_j_freeradbiomed_2004_09_007
crossref_primary_10_1080_10408398_2011_577540
crossref_primary_10_1002_pmic_201100668
crossref_primary_10_1021_acs_chemrestox_6b00443
crossref_primary_10_1016_j_bpc_2023_107069
crossref_primary_10_1111_j_1751_1097_2009_00593_x
crossref_primary_10_1074_jbc_M003263200
crossref_primary_10_1016_j_lwt_2014_12_037
crossref_primary_10_1093_gerona_59_9_B890
crossref_primary_10_1007_s13399_023_04847_w
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1042/bj3220317
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1470-8728
EndPage 325
ExternalDocumentID PMC1218194
9078279
10_1042_bj3220317
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NEI NIH HHS
  grantid: 5R29 EY10697
– fundername: NIA NIH HHS
  grantid: AG11472
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
23N
2WC
3EH
3O-
53G
5GY
5RE
5VS
6J9
79B
AAHRG
AAYXX
ABJNI
ABPPZ
ACGFO
ACGFS
ACNCT
ADBBV
ADXHL
AEGXH
AENEX
AI.
AIAGR
AIZAD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
CS3
DU5
E3Z
EBS
EJD
F5P
H13
HH6
HYE
HZ~
K-O
L7B
MV1
MVM
N9A
O9-
OHT
OK1
P2P
RHI
RNS
RPM
RPO
TR2
TWZ
VH1
WH7
WOQ
X7M
XOL
XSW
Y6R
YNY
ZGI
ZXP
ZY4
~02
~KM
AABGO
ABTAH
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
7X8
5PM
ID FETCH-LOGICAL-c436t-131a1d51224014edc7c9fb4e663c3e1123abb578b408fd604b44eaa297b7b0333
ISSN 0264-6021
IngestDate Thu Aug 21 18:07:36 EDT 2025
Fri Jul 11 08:34:02 EDT 2025
Wed Feb 19 02:32:34 EST 2025
Thu Apr 24 23:08:41 EDT 2025
Tue Jul 01 03:42:26 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c436t-131a1d51224014edc7c9fb4e663c3e1123abb578b408fd604b44eaa297b7b0333
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://portlandpress.com/biochemj/article-pdf/322/1/317/624099/bj3220317.pdf
PMID 9078279
PQID 78905339
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_1218194
proquest_miscellaneous_78905339
pubmed_primary_9078279
crossref_citationtrail_10_1042_bj3220317
crossref_primary_10_1042_bj3220317
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1997-02-15
1997-Feb-15
19970215
PublicationDateYYYYMMDD 1997-02-15
PublicationDate_xml – month: 02
  year: 1997
  text: 1997-02-15
  day: 15
PublicationDecade 1990
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Biochemical journal
PublicationTitleAlternate Biochem J
PublicationYear 1997
SSID ssj0014040
Score 2.033486
Snippet Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are major end-products of oxidation of polyunsaturated fatty acids, and are frequently measured as indicators...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 317
SubjectTerms Aldehydes - metabolism
Amino Acids - chemistry
Collagen - metabolism
Copper - metabolism
Crystallins - metabolism
Drug Stability
Gas Chromatography-Mass Spectrometry
Humans
Lipid Peroxidation
Lipoproteins, LDL - metabolism
Lysine - chemistry
Lysine - metabolism
Malondialdehyde - metabolism
Oxidation-Reduction
Ribonucleases
Schiff Bases
Skin - metabolism
Title Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein
URI https://www.ncbi.nlm.nih.gov/pubmed/9078279
https://www.proquest.com/docview/78905339
https://pubmed.ncbi.nlm.nih.gov/PMC1218194
Volume 322
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fj5NAEN_U80FfjN55sf7dGGNMGiqwW5BHPGuaJtfkzDXpW8PCkmJ6cLEQvfsAfh4_ojMM7NH2Hk5fCAGWAPNjdmZn5jeMvUulk_hSCct3U2FJkSpLKfBSRjrQkRdoqVJchzydeZO5nC5Gi17vTydrqSrVML6-ta7kf6QKx0CuWCX7D5I1N4UDsA_yhS1IGLZ3kvFZFVGuj7H7LqJ1kWMtSKJXVwmFBqQFu5itAp6-RuMTlE2FORxgdiIhSY6dU-Dhqzo3a5ATFTiOLH5lSXYNJil18lsXP60EE96x20R2WdQcDw1zdxsXzrADF1EQdF8BQzrjs_l4FlJKzQYD9J_DzeDb0CBoTmn8-WCRGcSGk9PxF6opWpWRGszN5dPxDFceqEgH12YG0-HNEgbRv7oWFXE2mg6sMsuzqVR6qEkTS98GVd1UjjeqWrjuHiZJ8QqqAG3mcEHF1HvTA2gokKn6DvexzYguBffO1GgSFutQvXSXZug9dt8Fx8Rp14eauJW0ZbOqRy_UcllJ96MZum0B7bk1u9m5HXPn_DF71PgpPCTQPWE9nR-yoxDAUVxc8fe8zhyuQzKH7MFJ2zXwiP3exiQvUr6DSQ7I4ruY5A0meVlwwiRvMcmznBMm65EtJnmNSd7BJO9g8imbfx2fn0yspteHFUvhlZYjnMhJRhjnha8IL-_HQaqkBoM4FhqcAhEpBbOLkvanNPFsqaTUUeQGvvKVLYQ4Zgf4xM8YVy4Mx1RAZxRJW6cK-ZY8mNrAF0piW_fZh_b7L-OGCB_7sayXe1Lus7fm0ktif7ntojetEJfwsTHgFuW6qDZLLDIHdyros2MSqblJgJa5Dyf8LVmb80j6vn0mz1Y1-buDNnkgn9_lyV6whze_20t2UP6o9CuwoUv1uobtX-dUzBY
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+malondialdehyde+and+4-hydroxynonenal+adducts+to+lysine+residues+in+native+and+oxidized+human+low-density+lipoprotein&rft.jtitle=Biochemical+journal&rft.au=REQUENA%2C+Jes%C3%BAs+R.&rft.au=FU%2C+Min+Xin&rft.au=AHMED%2C+Mahtab+U.&rft.au=JENKINS%2C+Alicia+J.&rft.date=1997-02-15&rft.issn=0264-6021&rft.eissn=1470-8728&rft.volume=322&rft.issue=1&rft.spage=317&rft.epage=325&rft_id=info:doi/10.1042%2Fbj3220317&rft.externalDBID=n%2Fa&rft.externalDocID=10_1042_bj3220317
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0264-6021&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0264-6021&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0264-6021&client=summon